News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Gunsagar Gulati: Two extraordinary papers released on BioRxiv
Photo from Gunsagar Gulati/X
Jul 31, 2024, 11:17

Gunsagar Gulati: Two extraordinary papers released on BioRxiv

Gunsagar Gulati, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X about two recent articles, commenting:

“Two extraordinary papers released today on BioRxiv:

  1. Mechanism behind cardiac benefit from SGLT2i, The Arany lab.
  2. Novel strategy for drugging P53-mutant cancers, William Gibson.

It’s an exciting time to be in physician-science!”

SGLT2 inhibitors activate pantothenate kinase in the human heart

Authors: Nicholas Forelli, Deborah Eaton, Jiten Patel, Caitlyn Bowman, Ryo Kawakami, Ivan Kuznetsov, Kristina Li, Claire Brady, Kenneth Bedi, Yijun Yang, Kaustubh Koya, Emily Megill, Daniel Kanter, Louis Smith, Gregory Bowman, Nathaniel Snyder, Jonathan Edwards, Kenneth Margulies, Zoltan Arany.

Gunsagar Gulati

p53 protein abundance is a therapeutic window across TP53 mutant cancers and is targetable with proximity inducing small molecules

Authors: Ananthan Sadagopan, Nicholas Garaffo, Heng-Jui Chang, Stuart Schreiber, Matthew Meyerson, William Gibson.

Gunsagar Gulati

Source: Gunsagar Gulati/X

Ananthan Sadagopan bioRxiv Caitlyn Bowman cancer Claire Brady Dana-Farber Cancer Institute Deborah Eaton Gunsagar Gulati Heng-Jui Chang Ivan Kuznetsov Jiten Patel Kenneth Bedi Kristina Li Matthew Meyerson Nicholas Forelli Nicholas Garaffo OncoDaily Oncology p53 P53-mutant cancers Ryo Kawakami SGLT2i Stuart Schreiber The Arany lab William Gibson Yijun Yang
Special Coverage
Career
Dec 22, 2024, 05:19
Sidra Naz has been honored with the 2025 Early Career Investigator Award in Healthcare Disparities Research in IBD
Blog
Dec 22, 2024, 05:17
Rasha Aboelhassan: Oncologists are overwhelmed by their own fights against cancer
Blog
Dec 22, 2024, 05:15
Jemma Arakelyan: Collaboration plans between City University of Hong Kong and Shenzhen Hospital of Southern Medical University
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS